Clinical Trial Update: Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing once-daily versus twice-daily silodosin for lower urinary tract symptoms due to benign prostatic hyperplasia reports safety and effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Rapaflo (silodosin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Benign Prostatic Hypertrophy | Phase 4 | Status: COMPLETED